GE HealthCare Technologies Inc. GEHC
Set alert
80.44 USD +0.89 +1.11%
As of Nov 3, 11:10 AM ET
78.96 Day range 80.62
59.49 52-week range 88.16
- YTD
- -1.93%
- 1 year
- +8.01%
- Open
- 79.42
- Prev close
- 79.55
- Mkt cap
- 36.35B
- Vol
- 1.08M
- Avg vol
- 3.41M
- EPS
- 4.73
- P/E
- 17.00
- Div yield
- 0.21%
More statistics
- Low
- 78.96
- High
- 80.62
- Forward P/E
- 14.52
- Beta
- 0.77
- Short ratio
- 4.91
- Inst. own
- 94.30%
- Dividend
- 0.16
- Ex-div date
- Oct 22, 2026
- Earnings
- Feb 3, 2027
- 50-d avg
- 68.45
- 200-d avg
- 69.82
- 1y target
- 87.50
MAX chart
Events in this range
- May 22, 2023Dividend: 0.03
- Jul 20, 2023Dividend: 0.03
- Oct 19, 2023Dividend: 0.03
- Jan 12, 2024Dividend: 0.03
- Apr 15, 2024Dividend: 0.03
- Apr 18, 2024Dividend: 0.03
- Jul 19, 2024Dividend: 0.03
- Oct 18, 2024Dividend: 0.03
- Jan 14, 2025Dividend: 0.035
- Apr 25, 2025Dividend: 0.035
- Jul 25, 2025Dividend: 0.035
- Oct 24, 2025Dividend: 0.035
- Oct 29, 2025Earnings: 1.07; estimate 1.05; surprise 1.9%
- Jan 9, 2026Dividend: 0.035
- Feb 4, 2026Earnings: 1.44; estimate 1.4; surprise 2.86%
- Apr 2, 2026Dividend: 0.035
- Apr 29, 2026Earnings: 0.99; estimate 1.04; surprise -4.81%
- Jul 24, 2026Dividend: 0.035
- Jul 29, 2026Earnings: 1.13; estimate 1.04; surprise 8.65%
- Oct 12, 2026Rating: BTIG · Buy → Buy
- Oct 23, 2026Dividend: 0.04
- Oct 28, 2026Earnings: 1.34; estimate 1.2; surprise 11.67%
- Oct 28, 2026Rating: BTIG · Buy → Buy
- Oct 29, 2026Rating: Barclays · Overweight → Overweight
- Oct 29, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 29, 2026Rating: Citigroup · Neutral → Neutral
- Oct 29, 2026Rating: JP Morgan · Neutral → Neutral
Signals (72)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 16, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 19, 2026 | 9 months ago |
| SMA: Bullish | Nov 17, 2025 | 11 months ago |
| SMA: Bullish | Nov 17, 2025 | 11 months ago |
Newest 20 of 72.
Analyst view
Consensus: buy
Buy
Price target (mean) 87.50 +8.8% upside
Now 80.44
- Target (low)
- 73.00
- Target (mean)
- 87.50
- Target (high)
- 100.00
Ratings (0m) 22 16 buy · 6 hold · 0 sell
- Strong buy6
- Buy10
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 22
- 1 month ago 20
- 2 months ago 19
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.56 | 1.53 – 1.60 | 1.44 | +8.1% | 5.92B | +3.9% | 16 |
| Next quarter | 1.12 | 0.99 – 1.25 | 0.99 | +12.8% | 5.37B | +4.6% | 11 |
| Current year | 5.02 | 4.99 – 5.06 | 4.59 | +9.4% | 21.86B | +6.0% | 19 |
| Next year | 5.48 | 5.09 – 5.67 | 5.02 | +9.2% | 22.92B | +4.8% | 21 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 29, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 28, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 12, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 7, 2026 | Barclays | Initiated | — | Overweight |
| Oct 5, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 5, 2026 | Needham | Reiterated | Buy | Buy |
| Sep 22, 2026 | Needham | Initiated | — | Buy |
| Sep 17, 2026 | BTIG | Reiterated | Buy | Buy |
| Aug 19, 2026 | BTIG | Reiterated | Buy | Buy |
| Jul 31, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 30, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 30, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 29, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 17, 2026 | Hovde Group | Initiated | — | Market Perform |
| Jul 16, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 9, 2026 | BMO Capital | Initiated | — | Market Perform |
| Jun 23, 2026 | RBC Capital | Initiated | — | Outperform |
| May 21, 2026 | UBS | Upgrade | Sell | Neutral |
| Apr 30, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 30, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Apr 30, 2026 | Goldman Sachs | Downgrade | Buy | Neutral |
| Apr 30, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 30, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Apr 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 29, 2026 | BTIG | Maintained | Buy | Buy |
| Apr 21, 2026 | BTIG | Reiterated | Buy | Buy |